ロード中...

Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension.

The antihypertensive effect of labetalol, a new alpha- and beta-adrenoceptor inhibiting agent, was studied in 20 patients in a double-blind crossover trial. A dose of 300 mg daily reduced blood pressure only moderately in the supine position, though in the sitting and standing positions the effect w...

詳細記述

保存先:
書誌詳細
主要な著者: Frick, M H, Pörsti, P
フォーマット: Artigo
言語:Inglês
出版事項: 1976
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1639910/
https://ncbi.nlm.nih.gov/pubmed/773498
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!